Home > Boards > US OTC > Medical - Equipment > Sangui Biotech International, Inc. (SGBI)

$SGBI - FDA GRANTS FAST TRACK DESIGNATION TO GRANULOX

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
paulsbest Member Profile
 
Followed By 4
Posts 603
Boards Moderated 0
Alias Born 08/30/11
160x600 placeholder
paulsbest   Tuesday, 11/14/17 08:49:48 AM
Re: None
Post # of 119 
$SGBI - FDA GRANTS FAST TRACK DESIGNATION TO GRANULOX

FDA FAST Track Designation

FDA grants FAST TRACK DESIGNATION

Witten, November, 13, 2017: Infirst Healthcare Ltd has announced that the United States (US) Food and Drug Administration (FDA) has granted Fast Track designation to Granulox 10% haemoglobin spray (porcine haemoglobin) for the treatment of diabetic foot ulcers (DFUs). It is the first and only haemoglobin spray to receive Fast Track designation – a process designed by the FDA to facilitate the development, and expedite the review of, new therapies to treat serious conditions and fill an unmet medical need.

Wowsers! $$$ Big gainer this one! $$$ GLTA



Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist